Sanofi and Regeneron’s Dupixent Receives the MHLW’s Approval to Treat Chronic Obstructive Pulmonary Disease (COPD)
Shots: Japan’s MHLW has approved Dupixent to treat COPD in adults whose dise...
BridgeBio Receives the MHLW’s Approval for Beyonttra (Acoramidis) for Transthyretin-Mediated Amyloidosis Cardiomyopathy (ATTR-CM)
Shots: Japan’s MHLW has approved Beyonttra to treat ATTR-CM in adult pts bas...
Merck Secures the EC’s Approval for Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) for Invasive Pneumococcal Disease (IPD)
Shots: The EC has approved Capvaxive for active immunization against invasive dise...
Exelixis Reports the US FDA’s Approval of Cabometyx (Cabozantinib) to Treat Advanced Neuroendocrine Tumors (NETs)
Shots: The US FDA has approved Cabometyx for treatment-experienced, inoperable, LA...
GSK Reports the US FDA’s Approval of Blujepa (Gepotidacin) to Treat Uncomplicated Urinary Tract Infections (uUTIs)
Shots: The US FDA has approved Blujepa to treat uUTIs in female adults (≥4...
SineuGene Therapeutics Reports the US FDA’s IND Clearance of SNUG01 for Amyotrophic Lateral Sclerosis
Shots: The US FDA has granted IND clearance to SNUG01 for ALS SNUG...
